Int J Sports Med 2003; 24(3): 208-211
DOI: 10.1055/s-2003-39093
Physiology & Biochemistry
© Georg Thieme Verlag Stuttgart · New York

Involvement of Endogenous Growth Hormone-Releasing Hormone (GHRH) in the Exercise-Related Response of Growth Hormone

W. R.  de Vries1 , T. J.  Schers1 , S.  Ait Abdesselam1 , M.  Osman-Dualeh2 , I.  Maitimu2 , H. P. F.  Koppeschaar2
  • 1 Department of Medical Physiology and Sports Medicine, University Medical Center Utrecht, The Netherlands
  • 2 Department of Endocrinology, University Medical Center Utrecht, Utrecht, The Netherlands
Further Information

Publication History



Accepted after revision: 25 September 2002

Publication Date:
12 May 2003 (online)

Abstract

The aim of this study was to investigate the involvement of endogenous growth hormone-releasing hormone (GHRH) in the growth hormone (GH) release during strenuous exercise (EX). Eight healthy male subjects (age: 22.1 ± 0.8 yr, body mass index: 22.2 ± 0.9 kg/m2, V˙O2max: 52.2 ± 0.5 ml/min/kg [mean ± SEM]) were exposed to incremental EX until volitional exhaustion (cycle ergometry), and in random order to a maximally stimulating bolus injection of 100 μg GHRH, or to combined administration of 100 μg GHRH and EX (GHRH+EX). Serial blood samples in the fasted state were taken immediately before the start of each trial, and at appropriate intervals over 2 h. Total GH availability was calculated as area under the response curve (AUC), corrected for differences in baseline values. The results showed that peak serum GH levels to GHRH alone and EX alone were not significantly different: 41.5 ± 9.0 μg/l and 64.1 ± 8.1(mean ± SEM). Peak GH level to GHRH+EX was 156.1 ± 19.9 μg/l, which was significantly greater than to either stimulus alone (p < 0.02) or additively (105.6 ± 17.1 μg/l, p < 0.02). AUC’s to GHRH alone and EX alone were not significantly different (3242 ± 839 vs. 2472 ± 408 μg/l × 120 min). AUC to GHRH+EX (7807 ± 1221μg/l × 120 min) was greater than to either stimulus alone (p < 0.02) or additively (5714 ± 1247 μg/l × 120 min, p < 0.02). This indicates a potentiating (synergistic) effect between GHRH and EX. We postulate that GH responses to strenuous EX are only partially due to maximal GHRH activation. Next to complete inhibition of hypothalamic somatostatin activity, which is achieved by strenuous exercise, activation of endogenous GH-releasing peptides, such as Ghrelin, must be operative.

References

  • 1 Casanueva F F, Villanueva L, Cabranes J A, Cabezas-Cerrato J, Fernandez-Cruz A. Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine and physical exercise in man.  J Clin Endocrinol Metab. 1984;  59 526-530
  • 2 Cuneo R C, Wallace J D. Growth hormone, insuline-like growth factors and sport.  Endocrinol Metab. 1994;  1 3-13
  • 3 Devesa J, Lima L, Lois N, Fraga C, Lechuga M J, Arce V, Tresguerres J AF. Reasons for the variability in growth hormone (GH) responses to GHRH challenge: the endogenous hypothalamic-somatotroph rhythm (HSR).  Clin Endocrinol. 1989;  30 367-377
  • 4 de Vries J H, Noorda R JP, Voetberg G A, van der Veen E A. Growth hormone release after the sequential use of growth hormone releasing factor and exercise.  Horm Metabol Res. 1991;  23 397-398
  • 5 Dieguez C, Casanueva F F. Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulation.  Eur J Endocrinol. 2000;  142 413-417
  • 6 Felsing N E, Brasel J A, Cooper D M. Effect of low and high intensity exercise on circulating growth hormone in men.  J Clin Endocrinol Metab. 1992;  75 157-162
  • 7 Few J D, Davies C T. The inhibiting effect of atropine on growth hormone release during exercise.  Eur J Appl Physiol. 1980;  43 221-228
  • 8 Fornito M C, Calogero A E, Mongioi A, Coniglione F, Vicari E, Moncada M L, D’Agata R, Merriam G R. Intra- and inter-individual variability in growth hormone responses to growth hormone-releasing hormone.  J Neuroendocrinol. 1990;  2 87-90
  • 9 Friedmann B, Kindermann W. Energy metabolism and regulatory hormones in women and men during endurance exercise.  Eur J Appl Physiol. 1989;  59 1-9
  • 10 Gelato M C, Pescovitz D H, Cassorla F, Loriaux D L, Merriam G R. Dose-response relationships for the effects of GH-releasing factor 1 - 44 NH2 in young adult men and women.  J Clin Endocrinol Metab. 1984;  59 197-203
  • 11 Gill M S, Toogood A A, O’Neill P A, Adams J E, Thorner M O, Shalet S M, Clayton P E. Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects.  Clin Endocrinol. 1997;  47 161-167
  • 12 Hansen A P. Serum growth hormone response to exercise in non-obese and obese normal subjects.  Scand J Clin Lab Invest. 1973;  31 175-178
  • 13 Hotta M, Shibasaki T, Masuda A, Imaki T, Wakabayashi I, Demura H, Ling N, Shuzome K. The inter- and intra-subject variabilities of plasma GH responses to human growth hormone (1 - 44) NH2 in men.  Endocrinol Jpn. 1985;  32 673-680
  • 14 Jaffe C A, DeMott-Friberg R, Barkan A L. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.  J Clin Invest. 1996;  97 934-940
  • 15 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo M, Kangawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
  • 16 Luger A, Watschinger B, Deuster P, Svoboda T, Clodi M, Chrousos G P. Plasma growth hormone and prolactin responses to graded levels of acute exercise and to a lactate infusion.  Neuroendocrinol. 1992;  56 112-117
  • 17 Lukaski H C, Johnson P E, Bolonchuk W W, Lykken G I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body.  Am J Clin Nutr. 1985;  41 810-817
  • 18 Lukaski H C, Bolonchuk W W. Theory and validation of the tetrapolar bioelectrical impedance method to assess human body composition. In: Ellis KJ, Yasumura S, Morgan WD (eds). In vivo body composition studies London; Inst Phys Med 1987: 410-414
  • 19 Maas H CM, de Vries W R, Maitimu I, Bol E, Bowers C Y, Koppeschaar H PF. Growth hormone (GH) responses during strenuous exercise: the role of GH-releasing hormone (GHRH) and GH-releasing peptide-2 (GHRP-2).  Med Sci Sports Exerc. 2000;  32 1226-1232
  • 20 Marcell T J, Wiswell R A, Hawkins S A, Tarpenning K M. Age-related blunting of growth hormone secretion during exercise may not be solely due to increased somatostatin tone.  Metab. 1999;  48 665-670
  • 21 Mazza E, Imperiale E, Procopio M, Boghen M F. Inter- and intra-individual variability in the GH response to GHRH: Effects of cholinergic enhancement by pyridostigmine.  J Endocrinol Invest. 1988;  11(Suppl 2) 92-95
  • 22 Nooitgedagt A, Koppeschaar H PF, de Vries W R, Sidorowicz A, Klok L J, Dieguez C, Mallo F. Influence of endogenous cholinergic tone and growth hormone-releasing peptide-6 on exercise induced growth hormone release.  Clin Endocrinol. 1997;  46 195-202
  • 23 Peñalva A, Carballo A, Pombo M, Casanueva F F, Dieguez C. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.  J Clin Endocrinol Metabol. 1993;  76 168-171
  • 24 Rogol A D, Weltman J Y, Evans W S, Veldhuis J D, Weltman A. Long-term endurance training alters the hypothalamic-pituitary axes for gonadotropins and growth hormone.  Endocrinol Metab. 1992;  21 817-832
  • 25 Snegovskaya V, Viru A. Elevation of cortisol and growth hormone levels in the course of further improvement of performance capacity in trained rowers.  Int J Sports Med. 1993;  14 202-206
  • 26 Sutton J R, Jones N L, Toews C J. Growth hormone secretion in acid-base alternations at rest and during exercise.  Clin Sci Mol Med. 1976;  50 241-247
  • 27 Thompson D L, Weltman J Y, Rogol A D, Metzger D L, Veldhuis J D, Weltman A. Cholinergic and opioid involvement in release of growth hormone during exercise and recovery.  J Appl Physiol. 1993;  75 870-878
  • 28 Weltman A, Weltman J Y, Schurrer R, Evans W S, Veldhuis J D, Rogol A D. Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity.  J Appl Physiol. 1992;  72 2188-2196

W. R. de Vries, M.D., Ph.D.

Department of Medical Physiology and Sports Medicine · University Medical Center Utrecht

PO Box 85060 · 3508 AB Utrecht · The Netherlands ·

Phone: (31) 30 2538900

Fax: (31) 30 2539036

Email: W.R.deVries@med.uu.nl

    >